Cargando…

Expression and Alteration Value of Long Noncoding RNA AB073614 and FER1L4 in Patients with Acute Myeloid Leukemia (AML)

BACKGROUND: Numerous studies have probed the deregulation of the long noncoding RNA AB073614 and FER1L4, which have been discovered in a variety of cancers. However, the precise expression pattern of these lncRNAs and their clinical implications in acute myeloid leukemia (AML) remain elusive. Consid...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganji, Ali, Khosravi, Mahmood, Mosayebi, Ghasem, Gholami, Milad, Ghazavi, Ali, Keshavarzian, Nafiseh, Sayyadi, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676507/
https://www.ncbi.nlm.nih.gov/pubmed/37505756
http://dx.doi.org/10.31557/APJCP.2023.24.7.2271
_version_ 1785141296717889536
author Ganji, Ali
Khosravi, Mahmood
Mosayebi, Ghasem
Gholami, Milad
Ghazavi, Ali
Keshavarzian, Nafiseh
Sayyadi, Mohammad
author_facet Ganji, Ali
Khosravi, Mahmood
Mosayebi, Ghasem
Gholami, Milad
Ghazavi, Ali
Keshavarzian, Nafiseh
Sayyadi, Mohammad
author_sort Ganji, Ali
collection PubMed
description BACKGROUND: Numerous studies have probed the deregulation of the long noncoding RNA AB073614 and FER1L4, which have been discovered in a variety of cancers. However, the precise expression pattern of these lncRNAs and their clinical implications in acute myeloid leukemia (AML) remain elusive. Considering the involvement of the PI3K axis in AML pathogenesis, an investigation into the expression of AB073614 and FER1L4 targets of this pathway has been proposed, aiming to elucidate a potential mechanism underlying AML development. METHODS: The expression levels of lncRNA AB073614 and FER1L4 were assessed in 30 newly diagnosed AML patients and 12 healthy individuals using quantitative reverse transcription–polymerase chain reaction techniques. A statistical analysis was conducted to determine the association of AB073614 and FER1L4 expression levels with clinicopathological features. RESULTS: A significant upregulation of AB073614 was observed in AML patients compared to the control group (p < 0.05). Moreover, a notable increase in AB073614 expression levels coincided with a significant reduction in FER1L4 expression levels in AML samples (p < 0.05). The diagnostic value of these lncRNAs was validated using the receiver operating characteristic (ROC) curve and area under the curve (AUC) calculations. Sensitivity values of AB073614 and FER1L4 gene expression were 96.7% and 100%, respectively, using cut-off relative quantification of 1.045 and 0.770. Additionally, specificity values were observed to be 100%. CONCLUSIONS: The present study indicates that AB073614 and FER1L4 might serve as prognosis biomarkers in AML patients. However, further detailed examinations in this field are warranted. It is proposed that the likely mechanism of imbalanced PI3K and PTEN activity, triggered by the deregulation of AB073614 and FER1L4, may have a crucial role in AML pathogenesis. Any component of this pathway could potentially serve as a new target for more insightful treatment approaches.
format Online
Article
Text
id pubmed-10676507
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-106765072023-03-01 Expression and Alteration Value of Long Noncoding RNA AB073614 and FER1L4 in Patients with Acute Myeloid Leukemia (AML) Ganji, Ali Khosravi, Mahmood Mosayebi, Ghasem Gholami, Milad Ghazavi, Ali Keshavarzian, Nafiseh Sayyadi, Mohammad Asian Pac J Cancer Prev Research Article BACKGROUND: Numerous studies have probed the deregulation of the long noncoding RNA AB073614 and FER1L4, which have been discovered in a variety of cancers. However, the precise expression pattern of these lncRNAs and their clinical implications in acute myeloid leukemia (AML) remain elusive. Considering the involvement of the PI3K axis in AML pathogenesis, an investigation into the expression of AB073614 and FER1L4 targets of this pathway has been proposed, aiming to elucidate a potential mechanism underlying AML development. METHODS: The expression levels of lncRNA AB073614 and FER1L4 were assessed in 30 newly diagnosed AML patients and 12 healthy individuals using quantitative reverse transcription–polymerase chain reaction techniques. A statistical analysis was conducted to determine the association of AB073614 and FER1L4 expression levels with clinicopathological features. RESULTS: A significant upregulation of AB073614 was observed in AML patients compared to the control group (p < 0.05). Moreover, a notable increase in AB073614 expression levels coincided with a significant reduction in FER1L4 expression levels in AML samples (p < 0.05). The diagnostic value of these lncRNAs was validated using the receiver operating characteristic (ROC) curve and area under the curve (AUC) calculations. Sensitivity values of AB073614 and FER1L4 gene expression were 96.7% and 100%, respectively, using cut-off relative quantification of 1.045 and 0.770. Additionally, specificity values were observed to be 100%. CONCLUSIONS: The present study indicates that AB073614 and FER1L4 might serve as prognosis biomarkers in AML patients. However, further detailed examinations in this field are warranted. It is proposed that the likely mechanism of imbalanced PI3K and PTEN activity, triggered by the deregulation of AB073614 and FER1L4, may have a crucial role in AML pathogenesis. Any component of this pathway could potentially serve as a new target for more insightful treatment approaches. West Asia Organization for Cancer Prevention 2023 /pmc/articles/PMC10676507/ /pubmed/37505756 http://dx.doi.org/10.31557/APJCP.2023.24.7.2271 Text en https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Research Article
Ganji, Ali
Khosravi, Mahmood
Mosayebi, Ghasem
Gholami, Milad
Ghazavi, Ali
Keshavarzian, Nafiseh
Sayyadi, Mohammad
Expression and Alteration Value of Long Noncoding RNA AB073614 and FER1L4 in Patients with Acute Myeloid Leukemia (AML)
title Expression and Alteration Value of Long Noncoding RNA AB073614 and FER1L4 in Patients with Acute Myeloid Leukemia (AML)
title_full Expression and Alteration Value of Long Noncoding RNA AB073614 and FER1L4 in Patients with Acute Myeloid Leukemia (AML)
title_fullStr Expression and Alteration Value of Long Noncoding RNA AB073614 and FER1L4 in Patients with Acute Myeloid Leukemia (AML)
title_full_unstemmed Expression and Alteration Value of Long Noncoding RNA AB073614 and FER1L4 in Patients with Acute Myeloid Leukemia (AML)
title_short Expression and Alteration Value of Long Noncoding RNA AB073614 and FER1L4 in Patients with Acute Myeloid Leukemia (AML)
title_sort expression and alteration value of long noncoding rna ab073614 and fer1l4 in patients with acute myeloid leukemia (aml)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676507/
https://www.ncbi.nlm.nih.gov/pubmed/37505756
http://dx.doi.org/10.31557/APJCP.2023.24.7.2271
work_keys_str_mv AT ganjiali expressionandalterationvalueoflongnoncodingrnaab073614andfer1l4inpatientswithacutemyeloidleukemiaaml
AT khosravimahmood expressionandalterationvalueoflongnoncodingrnaab073614andfer1l4inpatientswithacutemyeloidleukemiaaml
AT mosayebighasem expressionandalterationvalueoflongnoncodingrnaab073614andfer1l4inpatientswithacutemyeloidleukemiaaml
AT gholamimilad expressionandalterationvalueoflongnoncodingrnaab073614andfer1l4inpatientswithacutemyeloidleukemiaaml
AT ghazaviali expressionandalterationvalueoflongnoncodingrnaab073614andfer1l4inpatientswithacutemyeloidleukemiaaml
AT keshavarziannafiseh expressionandalterationvalueoflongnoncodingrnaab073614andfer1l4inpatientswithacutemyeloidleukemiaaml
AT sayyadimohammad expressionandalterationvalueoflongnoncodingrnaab073614andfer1l4inpatientswithacutemyeloidleukemiaaml